Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Return on Equity (2016 - 2025)

Historic Return on Equity for Standard Biotools (LAB) over the last 15 years, with Q3 2025 value amounting to 0.29%.

  • Standard Biotools' Return on Equity fell 1400.0% to 0.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.29%, marking a year-over-year decrease of 1400.0%. This contributed to the annual value of 0.86% for FY2024, which is 15100.0% down from last year.
  • Per Standard Biotools' latest filing, its Return on Equity stood at 0.29% for Q3 2025, which was down 1400.0% from 0.28% recorded in Q2 2025.
  • Over the past 5 years, Standard Biotools' Return on Equity peaked at 21.26% during Q2 2022, and registered a low of 2.0% during Q1 2022.
  • Moreover, its 5-year median value for Return on Equity was 0.27% (2025), whereas its average is 1.31%.
  • As far as peak fluctuations go, Standard Biotools' Return on Equity soared by 217800bps in 2022, and later crashed by -204600bps in 2023.
  • Standard Biotools' Return on Equity (Quarter) stood at 0.61% in 2021, then surged by 532bps to 2.64% in 2022, then plummeted by -80bps to 0.54% in 2023, then tumbled by -152bps to 0.28% in 2024, then dropped by -5bps to 0.29% in 2025.
  • Its Return on Equity stands at 0.29% for Q3 2025, versus 0.28% for Q2 2025 and 0.27% for Q1 2025.